| Financial Year |
March 31 2023 |
| Monetary Funds |
4,428,483,106.28 |
| Held-for-trading Financial Assets |
1,675,776,561.64 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,120,121,726.69 |
| Advances to Suppliers |
95,153,381.74 |
| Other Receivables |
33,653,305.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,182,548,948.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
261,841,877.28 |
| Total Current Assets |
11,797,578,908.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,461,320.39 |
| Fixed Assetes |
3,740,579,789.56 |
| Under-construction Projects |
727,362,620.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
494,562,961.01 |
| R&D expenses |
-- |
| Goodwill |
124,981,840.86 |
| Long-Term Deferred and Prepaid Expenses |
176,752,813.59 |
| Deferred Income Tax Assets |
128,815,579.22 |
| Other Non-Current Assets |
180,002,062.50 |
| Sub-Total of Non-Current Assets |
5,917,082,715.10 |
| Total Assets |
17,714,661,623.24 |
| Short-Term Loans |
1,169,714,636.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
483,794.41 |
| Accounts Payable |
1,437,763,108.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
884,379,544.98 |
| Taxes Payable |
358,418,491.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,589,021.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,302,709.25 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
3,950,705,544.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
64,311,611.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
171,551,689.47 |
| Total Liabilities |
4,122,257,233.62 |
| Paid-In Capital(Or Share Stock) |
1,167,000,000.00 |
| Capital Surplus |
5,703,721,520.42 |
| Surplus Reserve |
437,241,527.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,821,754,488.22 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,592,404,389.62 |
| Owner's Equity（Stockholder's Equity） |
13,592,404,389.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,714,661,623.24 |
